VEGF receptor inhibitors block the ability of metronomically dosed cyclophosphamide to activate innate immunity-induced tumor regression

Thbs1)nHighlight:TSP1, in addition to its anti-angiogenic activity, has other actions, including stimulation of chemotaxis, cell proliferation, and protease regulation in healingnHighlight:tumors that stably express TSP1 have significantly increased levels of infiltrating anti-tumor M1 macrophages nHighlight:VEGF receptor-selective anti-angiogenic drugs block anti-tumor immunity and prevent metronomic CPA-induced tumor regressionn]]>

Picture of About Dr. Nathan Goodyear
About Dr. Nathan Goodyear

Dr. Nathan Goodyear, a medical doctor with years of experience in the field of integrative cancer care, has announced the launch of an online training program. This program, available on his new website, will provide individuals with access to video trainings led by Dr. Goodyear himself, covering a range of topics related to integrative cancer care. These trainings will include information on the latest research and techniques in the field, as well as guidance on how to incorporate these approaches into a patient’s overall cancer treatment plan. With this online program, Dr. Goodyear hopes to make his expertise and knowledge more widely accessible, and help more people understand the benefits of integrative cancer care.

READ MORE

Leave a Comment

Your email address will not be published. Required fields are marked *

Skip to content